Mucinous Cystadenoma Arising in Post-Treatment Non-Seminomatous Germ Cell Tumor: A Rare Occurrence
- PMID: 39723313
- PMCID: PMC11669379
- DOI: 10.7759/cureus.74375
Mucinous Cystadenoma Arising in Post-Treatment Non-Seminomatous Germ Cell Tumor: A Rare Occurrence
Abstract
Germ cell tumors, the most common of the testicular neoplasms, originate from primordial germ cells. These tumors are known for their totipotent nature, capable of differentiating into various cell types. This case report presents a rare occurrence of mucinous cystadenoma in a patient who received chemotherapy for metastatic left non-seminomatous germ cell tumor (NSGCT) of the testis. Despite undergoing chemotherapy, a residual retroperitoneal mass persisted. The persisting large mass is usually suggestive of teratoma or malignancy. Upon surgical removal, the histopathology revealed a surprising diagnosis: that of mucinous cystadenoma.
Keywords: mucinous tumours; retroperitoneal lymph node dissection; rplnd; testicular germ cell tumor; yolk-sac tumor.
Copyright © 2024, Agrawal et al.
Conflict of interest statement
Human subjects: Consent for treatment and open access publication was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Figures





Similar articles
-
[Clinical outcome of postchemotherapy retroperitoneal lymph node dissection and predicting retroperitoneal histology in advanced nonseminomatous germ cell tumours of the testis].Zhonghua Wai Ke Za Zhi. 2017 Aug 1;55(8):603-607. doi: 10.3760/cma.j.issn.0529-5815.2017.08.010. Zhonghua Wai Ke Za Zhi. 2017. PMID: 28789511 Chinese.
-
Retroperitoneal lymph node dissection with concomitant IVC thrombectomy, caval wall resection, and grafting for metastatic NSGCT.Int Braz J Urol. 2012 Jan-Feb;38(1):135; discussion 136. doi: 10.1590/s1677-55382012000100020. Int Braz J Urol. 2012. PMID: 22397783
-
Detailed pathologic analysis on the co-occurrence of non-seminomatous germ cell tumor subtypes in matched orchiectomy and retroperitoneal lymph node dissections.Med Oncol. 2018 Jan 31;35(3):21. doi: 10.1007/s12032-018-1090-y. Med Oncol. 2018. PMID: 29387987
-
Primary and Postchemotherapy Retroperitoneal Lymphadenectomy for Testicular Cancer.Oncol Res Treat. 2018;41(6):370-378. doi: 10.1159/000489508. Epub 2018 May 17. Oncol Res Treat. 2018. PMID: 29772568 Review.
-
Robot-assisted laparoscopic retroperitoneal lymph node dissection: a minimally invasive surgical approach for testicular cancer.Transl Androl Urol. 2020 Jan;9(Suppl 1):S66-S73. doi: 10.21037/tau.2019.12.36. Transl Androl Urol. 2020. PMID: 32055487 Free PMC article. Review.
References
-
- Trends in the incidence of testicular germ cell tumors in the United States. McGlynn KA, Devesa SS, Sigurdson AJ, Brown LM, Tsao L, Tarone RE. Cancer. 2003;97:63–70. - PubMed
-
- Germ cell testicular tumors - contemporary diagnosis, staging and management of localized and advanced disease. Goldberg H, Klaassen Z, Chandrasekar T, Fleshner N, Hamilton RJ, Jewett MA. Urology. 2019;125:8–19. - PubMed
-
- Mucinous cystic tumour of low malignant potential presenting in a patient with prior non-seminatous germ cell tumour. Chahal D, Martens M, Kinahan J. https://cuaj.ca/index.php/journal/article/view/2946/2402 Can Urol Assoc J. 2015;9:0–3. - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources